Standard Versus Hyperangulated Video Laryngoscopy Blades for Intubation in Neonates and Small Infants
Launched by AMERICAN UNIVERSITY OF BEIRUT MEDICAL CENTER · Apr 25, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to find out which type of video laryngoscope blade—either the hyperangulated Cobalt blade or the straight Miller blade—works better for helping doctors insert a breathing tube in newborns and small infants who weigh 5 kilograms or less and are under 3 months old. The researchers want to see if one blade improves the view of the airway and makes the intubation process easier and safer for these tiny patients. They will also check how many tries it takes to successfully insert the tube, how long it takes, and if there are any complications, like drops in heart rate or oxygen levels.
To participate, infants must be scheduled for elective surgery under general anesthesia and fit certain health criteria. Specifically, they should not have had any previous difficult airway experiences or certain health issues. The study will involve about 40 infants over a two-year period, and those who enroll can help contribute to understanding which blade is best, potentially improving safety during intubation in this vulnerable age group.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Neonates or small infants with body weight ≤ 5 kg or age ≤ 3 months, scheduled for elective surgery under general anesthesia.
- • ASA (American Society of Anesthesiologists) class I-III patients.
- Exclusion Criteria:
- • Patients with a history of difficult airway or with craniofacial and airway anomalies.
- • ASA (American Society of Anesthesiologists) class IV patients.
- • Recent respiratory tract infection within the last 2 weeks.
About American University Of Beirut Medical Center
The American University of Beirut Medical Center (AUBMC) is a leading academic medical institution in the Middle East, dedicated to advancing healthcare through innovative research, education, and clinical excellence. As a prominent sponsor of clinical trials, AUBMC integrates cutting-edge scientific inquiry with patient-centered care to enhance therapeutic options and improve health outcomes. With a commitment to ethical standards and regulatory compliance, AUBMC collaborates with multidisciplinary teams to conduct rigorous trials that contribute to the global medical knowledge base and address critical health challenges in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beirut, , Lebanon
Patients applied
Trial Officials
Marie Aouad-Maroun, MD
Principal Investigator
American University of Beirut Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported